Loading grant details…
Active
NEW AGENTS COMMITTEE - PROJECT
Europe PMC
CRUKD/24/001 A CRUK first in human dose escalation Phase I/II trial of UCB4594, an anti-HLA-G1 mAb, as monotherapy and in combination in advanced cancer
| Funder | Cancer Research UK |
|---|---|
| Recipient Organization | Christie Nhs Foundation Trust |
| Country | United Kingdom |
| Start Date | Jan 01, 2023 |
| End Date | Mar 31, 2028 |
| Duration | 1,916 days |
| Number of Grantees | 1 |
| Roles | Award Holder |
| Data Source | Europe PMC |
| Grant ID | NACDDP-Sep22/100002 |
Grant Description
An abstract will be uploaded a later point
All Grantees
Christie Nhs Foundation Trust
Advertisement
Advertisement
Interested in applying for this grant?
Complete our application form to express your interest and we'll guide you through the process.
Apply for This GrantQuick Summary
Start Year
2023
End Year
2028
Grantees
1
Related Grants
Advertisement
